RVL PHARMACEUTICALS PLC

Analyst Reco. RVL Pharmaceuticals plc

Equities

RVLPQ

IE00BF2HDL56

Market Closed - OTC Markets Other stock markets 15:25:18 2024-06-17 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

04-12	North American Morning Briefing : Big Banks Kick -2-	DJ
03-21	North American Morning Briefing : Investors -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts RVL Pharmaceuticals Price Target to $3 From $4, Maintains Buy Rating	23-08-21	MT
Barclays Adjusts Price Target on RVL Pharmaceuticals to $2 From $3, Keeps Overweight Rating	23-05-01	MT
Barclays Adjusts Price Target on RVL Pharmaceuticals to $3 From $4, Reiterates Overweight Rating	22-10-25	MT
Jefferies Assumes RVL Pharmaceuticals at Hold With $2.50 Price Target	22-10-21	MT
Barclays Reinstates RVL Pharmaceuticals at Overweight With $4 Price Target	22-04-05	MT
HC Wainwright Starts Osmotica Pharmaceuticals at Buy With $5 Price Target	21-12-23	MT
OSMOTICA PHARMACEUTICALS : Cantor Fitzgerald Initiates Osmotica Pharmaceuticals at Overweight Rating With $6 Price Target	21-09-24	MT
OSMOTICA PHARMACEUTICALS : RBC Trims Price Target on Osmotica Pharmaceuticals to $7 From $8, Maintains Outperform Rating, Speculative Risk Qualifier	21-08-17	MT
OSMOTICA PHARMACEUTICALS : RBC Cuts Price Target on Osmotica Pharmaceuticals to $8 From $12, Maintains Outperform-Speculative Risk Rating	21-03-17	MT
OSMOTICA PHARMACEUTICALS : Truist Securities Adjusts Osmotica Pharmaceuticals PT to $8 From $11, Maintains Buy Rating	20-12-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer